Calendar Celgene

Equities

Delayed Nasdaq Other stock markets 04:00:00 2019-11-20 pm EST			5-day change	1st Jan Change
108.2 ^USD	+0.10%		-1.97%	+68.89%

2023	Sutro Biopharma, Inc. Receives a Notice of Termination from Celgene Corporation	CI
2021	Biocon Limited, Biocon Pharma Limited and Biocon Pharma Inc. Enters into A Confidential Settlement Agreement with Celgene Corporation	CI

29ee9556.B1W9Wrz49n5HgTcPOHAWzrd87JcRJhJmSiuouse8p1M.MwLNac-1kksLyVZjaSBlhIAZgPpaEXk0K1Pu5YT6kWp0OPwg-ZG3Sim1XA~19c2775be5ebddd6f1ce06498683662c

No events available

2019-07-30 07:30 am	Interim 2019 Earnings Release
2019-06-10	TraceLink FutureLink Barcelona Conference
2019-06-04 10:57 am	American Society of Clinical Oncology Meeting - Abstract #7501
2019-06-03 12:30 pm	American Society of Clinical Oncology Meeting - Abstract #7515
2019-06-03 12:30 pm	American Society of Clinical Oncology Meeting - Abstract #7514
2019-06-03 12:30 pm	American Society of Clinical Oncology Meeting - Abstract #7516
2019-06-03 12:30 pm	American Society of Clinical Oncology Meeting - Abstract #7513
2019-06-03 09:00 am	American Society of Clinical Oncology Meeting - Abstract #7057
2019-06-02 12:45 pm	American Society of Clinical Oncology Meeting - Abstract #8006
2019-06-02 10:45 am	American Society of Clinical Oncology Meeting - Abstract #4000
2019-06-01 02:15 pm	American Society of Clinical Oncology Meeting - Abstract #6637
2019-04-25 04:30 pm	Q1 2019 Earnings Release
2019-04-12 10:00 am	Extraordinary Shareholders Meeting - M&A Vote
2019-01-31 09:00 am	FY 2018 Earnings Call
2019-01-31 07:30 am	FY 2018 Earnings Release
2019-01-21	World Stem Cell Summit
2019-01-07 11:20 am	Alliance for Regenerative Medicine Cell & Gene Therapies Conference
2019-01-07 10:30 am	J.P. Morgan Healthcare Conference
2018-12-03 09:45 pm	American Society of Hematology Meeting - Abstract #999
2018-12-03 09:00 pm	American Society of Hematology Meeting - Abstract #4744

Fiscal Period	December	2014	2015	2016	2017	2018
Net sales Million USD	Released Forecast Spread	7 670 7 645 0.34%	9 256 9 241 0.16%	11 229 11 265 -0.32%	13 003 12 982 0.16%	15 281 15 211 0.46%
EBITDA Million USD	Released Forecast Spread	4 255 4 041 5.29%	4 942 5 063 -2.39%	6 681 6 700 -0.28%	8 014 8 146 -1.62%	9 109 9 165 -0.61%
EBIT Million USD	Released Forecast Spread	3 881 3 818 1.65%	4 812 4 739 1.55%	6 177 6 150 0.44%	7 543 7 607 -0.85%	8 474 8 459 0.17%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	2 327 2 576 -9.65%	2 024 2 087 -3.06%	2 373 2 934 -19.14%	4 314 3 439 25.45%	4 832 5 287 -8.61%
Net income Million USD	Released Forecast Spread	2 000 2 042 -2.07%	1 602 1 677 -4.45%	1 999 2 002 -0.15%	2 940 3 192 -7.89%	4 046 4 270 -5.24%
EPS USD	Released Forecast Spread	2,39 2,44 -2.03%	1,94 2,03 -4.4%	2,49 2,54 -1.97%	3,64 3,94 -7.61%	5,51 5,63 -2.07%
Announcement Date		29/01/15	28/01/16	26/01/17	25/01/18	31/01/19